...
首页> 外文期刊>Vox Sanguinis: International Journal of Blood Transfusion and Immunohaematology >Storage of Buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability.
【24h】

Storage of Buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability.

机译:血沉棕黄层衍生的血小板在添加剂溶液中的储存:通过新型TACSI系统制备的血小板的体外效应,并储存在具有不同透气性的塑料容器中。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The novel TACSI system is designed for automated preparation of platelets (PLTs) from pooled buffy coats (BCs). One TACSI device will handle 6 units at the same time. The aim of our in vitro study is to investigate the effects of using this automated equipment with subsequent storage in two different plastic containers and to compare these results with PLTs prepared by the OrbiSac system. STUDY DESIGN AND METHODS: Buffy-coat-derived PLTs (n=8) were prepared by using the TACSI system, including storage in polyvinyl chloride (PVC)-based plastic containers with di, n-decyl phthalate (DnDP) (TACSI R) and BTHC (TACSI T)-based plasticizers. As a reference, the OrbiSac System was used to prepare PLTs (n=8) with subsequent storage in a PVC plastic container with a citrate-based plasticizer (BTHC). In total, 16 TACSI and eight reference units, supplied by approximately 30% plasma and 70% SSP+, were analysed for various in vitro variables during the 7-day storage period. RESULTS: No significant difference in PLT counts, LDH, mean platelet volume (MPV) and adenosine triphosphate between the groups was detected. Glucose was lower (P<0.05) and lactate was higher (P<0.05) in TACSI R vs. OrbiSac. With exception of day 7 (P<0.05 TACSI R vs. OrbiSac), HSR reactivity were not different between groups. Extent of shape change was lower and CD62P higher in TACSI T when compared with TACSI R and OrbiSac units (P<0.05). pH was maintained at >6.8 (day 7) and swirling remained at the highest level (score=2) for all units throughout storage. CONCLUSION: Platelets prepared by the TACSI system with subsequent storage in two different PVC-based plastic containers were equivalent to reference PLTs with regard to in vitro characteristics during 7 days of storage.
机译:背景:新颖的TACSI系统设计用于从合并的血沉棕黄层(BC)中自动制备血小板(PLT)。一台TACSI设备将同时处理6个单元。我们体外研究的目的是调查使用此自动化设备并将其随后存储在两个不同的塑料容器中的效果,并将这些结果与OrbiSac系统制备的PLT进行比较。研究设计和方法:使用TACSI系统制备血沉棕黄层的PLT(n = 8),包括将其与邻苯二甲酸二正癸酯(DnDP)(TACSI R)一起存储在聚氯乙烯(PVC)基塑料容器中。以及基于BTHC(TACSI T)的增塑剂。作为参考,使用OrbiSac系统制备PLT(n = 8),然后将其存储在带有柠檬酸盐基增塑剂(BTHC)的PVC塑料容器中。在7天的存储期内,总共分析了约30%血浆和70%SSP +提供的16个TACSI和8个参考单位的各种体外变量。结果:两组之间的PLT计数,LDH,平均血小板体积(MPV)和三磷酸腺苷均无显着差异。与OrbiSac相比,TACSI R中的葡萄糖含量较低(P <0.05),而乳酸含量较高(P <0.05)。除第7天(P <0.05 TACSI R vs. OrbiSac)外,两组之间的HSR反应性无差异。与TACSI R和OrbiSac单位相比,TACSI T的形状变化程度较低,而CD62P较高(P <0.05)。在整个存储过程中,所有单元的pH均保持在> 6.8(第7天),涡流保持在最高水平(得分= 2)。结论:TACSI系统制备的血小板随后在两个不同的基于PVC的塑料容器中储存,在储存7天的体外特性方面与参考PLT相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号